These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies. Baldini F; Khalil M; Bartolozzi A; Vassalli M; Di Ciaula A; Portincasa P; Vergani L Biomolecules; 2022 May; 12(5):. PubMed ID: 35625660 [TBL] [Abstract][Full Text] [Related]
11. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation. Huggett ZJ; Smith A; De Vivo N; Gomez D; Jethwa P; Brameld JM; Bennett A; Salter AM Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615698 [TBL] [Abstract][Full Text] [Related]
13. Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non-Alcoholic Fatty Liver Disease in mice. Kochan K; Maslak E; Krafft C; Kostogrys R; Chlopicki S; Baranska M J Biophotonics; 2015 Jul; 8(7):597-609. PubMed ID: 25346221 [TBL] [Abstract][Full Text] [Related]
14. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis. Vergani L Curr Med Chem; 2019; 26(19):3439-3456. PubMed ID: 28521680 [TBL] [Abstract][Full Text] [Related]
15. Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy. Minamikawa T; Ichimura-Shimizu M; Takanari H; Morimoto Y; Shiomi R; Tanioka H; Hase E; Yasui T; Tsuneyama K Sci Rep; 2020 Oct; 10(1):18548. PubMed ID: 33122711 [TBL] [Abstract][Full Text] [Related]
16. A new perspective on NAFLD: Focusing on lipid droplets. Scorletti E; Carr RM J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866 [TBL] [Abstract][Full Text] [Related]
17. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD. Bórquez JC; Díaz-Castro F; La Fuente FP; Espinoza K; Figueroa AM; Martínez-Ruíz I; Hernández V; López-Soldado I; Ventura R; Domingo JC; Bosch M; Fajardo A; Sebastián D; Espinosa A; Pol A; Zorzano A; Cortés V; Hernández-Alvarez MI; Troncoso R Metabolism; 2024 Mar; 152():155765. PubMed ID: 38142958 [TBL] [Abstract][Full Text] [Related]
18. The role of hepassocin in the development of non-alcoholic fatty liver disease. Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031 [TBL] [Abstract][Full Text] [Related]
19. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD. Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655 [TBL] [Abstract][Full Text] [Related]
20. Disruption of HSD17B12 in mouse hepatocytes leads to reduced body weight and defect in the lipid droplet expansion associated with microvesicular steatosis. Heikelä H; Mairinoja L; Ruohonen ST; Rytkönen KT; de Brot S; Laiho A; Koskinen S; Suomi T; Elo LL; Strauss L; Poutanen M FASEB J; 2024 Sep; 38(17):e70034. PubMed ID: 39248019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]